Innovation-Driven, Quality First, Creating a Healthy Future
ZHUHAI HRD PHARMACEUTICAL CO., LTD. has occupied an important position in the global pharmaceutical industry since its establishment in 2009. The company is committed to the innovation and application of pharmaceutical technology. It is a modern pharmaceutical enterprise dedicated to providing high-quality and high-standards pharmaceutical products and services to customers around the world.
The core concept of HRD Pharm is“Embrace the rivers, be auspicious and virtuous, with a heart of benevolence, bestowing blessings upon the people”. This guiding ideology emphasizes its relentless pursuit of excellence, innovation and deep commitment to global health.
Innovation and technology as the core, HRD Pharm has always been at the forefront of pharmaceutical innovation. The company has invested heavily in introducing advanced technology and equipment, bringing together some of the brightest minds in the industry. The company has developed dozens of raw materials and intermediates,including products like Oseltamivir Phosphate, llaprazole, Bilastine, Dotinurad, Tedizolid Phosphate, Methylene Blue trihydrate, Fimasartan, Zonisamide, Baricitinib, Edoxaban (Tosylate Monohydrate), Flurbiprofen and other products.
This joint effort on innovation is reflected in their product development process and the sophisticated methods they adopt. The company's cutting-edge technology is the key to its success in drug innovation. For example, HRD Pharm has mastered the precise control of high-temperature and low-temperature reactions, which is a key factor in drug stability and efficacy. This precision enables them to develop Apis (active pharmaceutical ingredients) and drug intermediates that meet strict quality standards.
Additionally, HRD Pharm’s expertise in hydrogenation reactions demonstrates its capabilities during chemical synthesis, which is the addition of hydrogen to a compound. This skill is essential for the production of a variety of drugs, especially those that require the conversion of unsaturated compounds into saturated compounds. Another area where HRD Pharm has demonstrated great expertise is in azide reactions. Despite the challenges of handling azides, which are highly reactive and potentially hazardous, HRD Pharm has developed innovative designs that allow for the safe and efficient integration of azide groups into target molecules. This capability is particularly important when synthesizing complex pharmaceutical compounds.
Additionally, HRD Pharm is leading the way in microchannel nitration reactions. This cutting-edge technology involves conducting nitration reactions within microchannels, which provides enhanced control over reaction parameters and improves the yield and purity of the final product. This innovation reduces the risk of side reactions and improves the overall efficiency of the nitration process.
